U
About
Umlaut.bio is a biotechnology company focused on developing novel immunotherapies for cancer. They leverage their proprietary platform to discover and develop new therapeutic candidates. The company has recently secured significant pre-seed funding to advance its research and development efforts.
Technology stack
detected 2026-06-15Est. monthly stack spend~$390/mo
Email
Microsoft 365
Hosting
self_managed
Stack
jQuery
Bootstrap
WordPress
SEO
All in One SEO
Maps
Google Maps
Compliance
GDPR
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Umlaut.bio do?
Umlaut.bio is a biotechnology company focused on developing novel immunotherapies for cancer. They leverage their proprietary platform to discover and develop new therapeutic candidates. The company has recently secured significant pre-seed funding to advance its research and development efforts.
How much funding has Umlaut.bio raised?
Umlaut.bio has raised a total of $3M in funding. The most recent round on record is Pre-Seed.
Where is Umlaut.bio headquartered?
Umlaut.bio is headquartered in Cambridge, Massachusetts, USA.
When was Umlaut.bio founded?
Umlaut.bio was founded in 2022.
What industry does Umlaut.bio operate in?
Umlaut.bio operates in Biotechnology, Cancer, Immunotherapy, Drug Discovery.